Sun F F, McGuire J C, Morton D R, Pike J E, Sprecher H, Kunau W H
Prostaglandins. 1981 Feb;21(2):333-43. doi: 10.1016/0090-6980(81)90151-9.
Eighteen acetylenic fatty acids were tested as inhibitors of human platelet arachidonic acid 12-lipoxygenase. 4,7,10,13-Eicosatetraynoic (4,7,10,13-ETYA) acid emerged as the most potent compound. Additional experiments have shown that 4,7,10,13-ETYA selectively blocked the 12-lipoxygenase in washed human platelets with lesser activity against the cyclooxygenase. The ID50 value for lipoxygenase was 7.8 microM in comparison with an ID50 of 100 microM for the cyclooxygenase. The commonly used inhibitor 5,8,11,14-eicosatetraynoic acid inhibited both enzymes with equal potency. It appears that 4,7,10,13-ETYA may be a valuable lead for selective modulation of the 12-lipoxygenase pathway in platelet or other target tissues.
对18种炔脂肪酸作为人血小板花生四烯酸12-脂氧合酶抑制剂进行了测试。4,7,10,13-二十碳四烯酸(4,7,10,13-ETYA)成为最有效的化合物。进一步的实验表明,4,7,10,13-ETYA能选择性地阻断洗涤过的人血小板中的12-脂氧合酶,而对环氧化酶的活性较低。脂氧合酶的ID50值为7.8微摩尔,而环氧化酶的ID50为100微摩尔。常用抑制剂5,8,11,14-二十碳四烯酸对两种酶的抑制效力相同。看来4,7,10,13-ETYA可能是选择性调节血小板或其他靶组织中12-脂氧合酶途径的一个有价值的先导化合物。